Mostrar el registro sencillo del ítem

dc.contributor.author
Barchuk, Magalí  
dc.contributor.author
Schreier, Laura Ester  
dc.contributor.author
Berg, Gabriela Alicia  
dc.contributor.author
Miksztowicz, Verónica Julieta  
dc.date.available
2020-04-27T16:08:19Z  
dc.date.issued
2018-12  
dc.identifier.citation
Barchuk, Magalí; Schreier, Laura Ester; Berg, Gabriela Alicia; Miksztowicz, Verónica Julieta; Metalloproteinases in non-alcoholic fatty liver disease and their behavior in liver fibrosis; De Gruyter; Hormone Molecular Biology and Clinical Investigation; 41; 1; 12-2018; 1-7  
dc.identifier.issn
1868-1891  
dc.identifier.uri
http://hdl.handle.net/11336/103632  
dc.description.abstract
Non-alcoholic fatty liver disease (NAFLD) is a clinical entity of high prevalence in the world characterized by fatty infiltration of liver tissue in the absence of alcohol consumption. The natural history of the disease develops in successive phases reflected in different histological stages, with 10-20% of patients developing liver cirrhosis and fibrosis. Fibrosis is a basic connective tissue lesion defined by the increase of the fibrillary extracellular matrix (ECM) components in a tissue or organ. Matrix metalloproteinases (MMPs) constitute a family of endopeptidases, which are involved in ECM and basement membranes components degradation. Fibrogenic process is characterized by altered ECM composition, associated with modifications in MMPs behavior. The active cross-talk between adipose tissue and liver can be altered in pathologies associated to insulin resistance (IR), such as NAFLD. The role of adipokines on MMPs behavior in the liver could be partly responsible of liver damage during IR. The aim of this revision is to describe the behavior of MMPs in NAFLD and its role in the associated fibrosis.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
De Gruyter  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/  
dc.subject
ADIPOCYTOKINES  
dc.subject
FIBROSIS  
dc.subject
METALLOPROTEINASES  
dc.subject
NON-ALCOHOLIC FATTY LIVER  
dc.subject.classification
Otras Ciencias de la Salud  
dc.subject.classification
Ciencias de la Salud  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Metalloproteinases in non-alcoholic fatty liver disease and their behavior in liver fibrosis  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2020-03-10T12:23:53Z  
dc.journal.volume
41  
dc.journal.number
1  
dc.journal.pagination
1-7  
dc.journal.pais
Alemania  
dc.description.fil
Fil: Barchuk, Magalí. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina  
dc.description.fil
Fil: Schreier, Laura Ester. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina  
dc.description.fil
Fil: Berg, Gabriela Alicia. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina  
dc.description.fil
Fil: Miksztowicz, Verónica Julieta. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina  
dc.journal.title
Hormone Molecular Biology and Clinical Investigation  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.degruyter.com/view/journals/hmbci/41/1/article-20180037.xml  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1515/hmbci-2018-0037